Asbestos and silica are well-known fibrogenic dusts. However, there is no comprehensive understanding of the molecular and cellular events that lead to fibrosis as a consequence of asbestos or silica inhalation. Previous studies have shown that asbestos stimulates superoxide anion production in alveolar macrophages through the phospholipase C/protein kinase C pathway. In contrast, silica does not appear to activate this pathway nor stimulate superoxide anion production, but silica does stimulate cytokine release by some undetermined pathway. Therefore, using human alveolar macrophages isolated from normal healthy volunteers, we evaluated the potential involvement of intracellular calcium and tyrosine kinases as potential signal transduction pathways. In the absence of serum, crystalline silica, and to a lesser extent amorphous silica, caused a rapid and dose-dependent elevation of intracellular calcium coming from the extracellular space. However, in the presence of serum, which is required for silica-stimulated cytokine release, neither form of silica caused noticeable elevation of intracellular calcium. Silica, however, did increase the extent of tyrosine phosphorylation, most notably of proteins at approximately 46 and 50 kDa, suggesting activation of a tyrosine kinase pathway. Preincubation of alveolar macrophages for 24 hr with silica-primed human alveolar macrophages for enhanced interleukin-1 0 (IL-1 3) release stimulated by endotoxin (LPS) that was dose dependent. The enhanced LPS-stimulated release of IL-1i correlated with enhanced mitogen-activated protein kinase activity. Taken together, these results indicate that a tyrosine kinase pathway is activated during silica stimulation of human alveolar macrophages. -Environ Health Perspect 102(Suppl 10): 69-74 (1994) 
Introduction
Of all inhaled particulates, asbestos and silica are unique in their ability to cause lung fibrosis. Both are recognized as ubiquitous occupational fibrogenic agents, capable of inducing fibroblast proliferation and excess collagen production in the lung (1) . Although asbestos-and silica-induced lung fibrosis are relatively well described on an anatomic level, there is as yet no comprehensive understanding of the molecular and cellular events that lead to fibrosis as a consequence of asbestos or silica inhalation.
The alveolar macrophage occupies a key position in mediating the interaction between inhaled particulates and other lung cell types, such as lymphocytes and fibroblasts. In addition to its abilities to chemotax and phagocytose, the alveolar macrophage produces a wide variety of inflammatory and growth-mediating factors such as superoxide anion and cytokines (2, 3) . The alveolar macrophage is therefore hypothesized to play a central role in the development of particulateinduced pulmonary fibrosis (4) (5) (6) through the inappropriate release of effector molecules with bioactivity for lung cells in response to fibrogenic particulates. Alveolar macrophages from animals (7, 8) and healthy human volunteers (9) exposed to fibrogenic particulates in vitro release factors that enhance fibroblast growth. Consistent with these in vitro observations, it has been shown that alveolar macrophages recovered from animals exposed to fibrogenic particulates (10) and from individuals with interstitial lung disease (11) caused by asbestos, silica, or coal dust appear to be in an activated state, as reflected by their enhanced basal production of cytokines such as interleukin-l1 . A recent study indicates that basal levels of alveolar macrophage cytokine production are also elevated in those human subjects who have had extensive exposure to asbestos but who have no evidence of fibrosis (12) . Macrophages from these latter subjects were found to release elevated amounts of several effectors, including ILl,, tumor necrosis factor-a (TNF-a), interleukin-6, granulocyte-macrophage colony stimulating factor, and prostaglandin E2 (12) . Whether the release of these factors by alveolar macrophages exposed to particulates in vivo is a result of their direct interaction with the particulates, an indirect result of the interaction of the particulates with other lung cell types, or both, is not known.
Previous in vitro studies using alveolar macrophages isolated from guinea pigs and humans demonstrated that while chrysotile and crocidolite asbestos stimulate superoxide anion production, silica was not bioactive for the release of this effector molecule (13) . Furthermore, the pathway for asbestos stimulation of alveolar macrophage superoxide anion production involves the phospholipase C/protein kinase C pathway (14) and opening of verapamil-sensitive calcium channels (15) . In contrast, both chrysotile and silica stimulated cytokine release (e.g., TNF-ax and IL- 15) indicating either that the mechanism of silica stimulation was distinct from chrysotile or that chrysotile stimulated multiple pathways (16) .
Results from other laboratories using rodent alveolar macrophages indicate that silica can cause a marked elevation of intracellular calcium in vitro, implicating it as a potential intracellular signal (17, 18 Human Alveolar Macrophages Cells for these experiments were obtained by bronchoalveolar lavage of normal nonsmoking volunteers using methods described previously (19) . Typically, instillations of 240 to 300 ml of sterile saline resulted in recoveries of 200 to 260 ml of lavage fluid. Cells were isolated from the lavage fluid as described previously (13) [Calcium] i= Kd(F-FmIn(F -F), where Kd = 224 nM, F = relative level of intracellular fluorescence, Fmin = relative level of fluorescence with 10 mM EGTA after cell lysis with 0.1% Triton X-100, and F = relative level of fluorescence in the presence of 4 mM calcium.
Cultures for IL-, Release
Cells (1 x 106/ml) were cultured for 24 hr in the presence or absence of 33 or 133 pg/ml silica in medium 199 with 10% FCS. After 24 hr, lipopolysaccharide (LPS) at 10 pg/mI or 100 ng/ml was added to stimulate human alveolar macrophage IL-13 release for 24 hr. Cells were maintained in suspension by slow end-over-end tumbling in polypropylene tubes at 37°C. Incubations were terminated by pelleting the cells, and supernatants were frozen and stored at -80°C until assayed. IL-13 released into the supernatants was quantitated by EIA (Cayman Chemical, Ann Arbor, MI).
Immunoblotting for Phosphotyrosine
Cells were washed in phosphate-buffered saline, denaturated and subjected to SDS polyacrylamide gel electrophoresis. Fractionated proteins were transfered to nitrocellulose membranes by electroblotting. Membranes were stained with 2% Ponceau S (Sigma) to visualize protein transfer to the membranes. Membranes were incubated in blocking buffer (5% nonfat dry milk, Tris-buffered saline with sodium azide) for 16 hr at 4°C, and then with antiphosphotyrosine monoclonal antibody (Upstate Biochemical Inc. (UBI), Upstate, NY, clone 4G10) for 2 hr at room temperature. The membranes were rinsed with Tween 20 in Tris-buffered saline and incubated with horseradish peroxidase-conjugated goat antimouse immunoglobulin G (Amersham, Arlington Heights, IL) for 1 hr at room temperature. After rinsing with Tween 20 in Tris-buffered saline, the antibody-antigen complex was visualized by using enhanced chemiluminescence detection (Amersham) and by exposing the membranes to ECL film (Amersham) for 1 min.
Mitogen-activated Protein (MAP)
Kinase Activity The procedure was adapted from ClarkLewis et al. (22) . At various times after adding LPS, cells were solubilized for 30 min on ice in 50 mM Tris-150 mM saline buffer, pH 8.0, containing 1% Nonidet P-40, 1 mM EDTA, 100 pM sodium orthovanadate, 1 pg/ml each of pepstatin and leupeptin, 0.1% aprotinin, and 2 mM phenylmethylsulfonyl fluoride. The solubilized fraction was collected following centrifugation and divided into two aliquots. To the solubilized proteins, antihuman MAP kinase (UBI) was added to a final concentration of 1 pg/ml and incubated for 1 hr, then an equal volume of Protein A agarose (10% suspension in the same buffer) was added and incubated for another hour. The agarose beads were washed three times in the same buffer and then used for the kinase assay. For the kinase assay, 25 pl of reaction cocktail was added to the agarose beads that consisted of 2 mg/ml of MAP kinase substrate, APRTPGGRR (UBI), 1 pM ATP with 2 pCi/sample of [y-P]ATP, 12.5 mM MOPS (pH 7.2), 12.5 mM glycerol phosphate, 7.5 mM MgCl2, 0.5 mM EGTA, 0.05 mM NaF, 0.5 mM sodium orthovanadate, and 2 mM dithiothreitol. The reaction was allowed to proceed for 15 min and stopped by spotting the entire contents onto 2.1-cm circles of phosphocellulose paper. The papers were washed seven times with 1% phosphoric acid and the bound radioactivity determined by liquid scintillation counting. Negative controls included an irrelevant antibody.
Endotoxin
Endotoxin levels in buffers, media, and particulate stock suspensions were assessed by the Limulus amoebocyte assay (Sigma); endotoxin levels were in all cases found to be < 20 pg/ml. Statistics Values are presented as the mean, and error bars denote the standard error of the mean. The number of individuals from whom cells were obtained for a given experiment is denoted by "N" in the corresponding figure legend. For measurements of IL-i1 , statistical treatment was one-tailed paired t-test.
Results

Silica-induced Changes in Intracellular Calium
Previous studies using rodent alveolar macrophages have shown that silica can cause an elevation in intracellular calcium in vitro (17, 18) . Since elevation in intracellular calcium could serve to signal downstream events, the effect of silica on intracellular calcium in human alveolar Environmental Health Perspectives PARTICULATE STIMULATION OFALVEOLAR MACROPHAGE macrophages using Fura-2 fluorescence was examined. As shown in Figure 1 , crystalline silica caused a rapid and sustained elevation of intracellular calcium. Addition of 67 or 133 jig/ml silica caused intracellular calcium to increase from a baseline of approximately 150 nM to approximately 300 nM or almost 500 nM in approximately 9 min, respectively. In contrast, intracellular calcium remained constant in untreated cells. Furthermore, there was no change in intracellular calcium following silica addition to cells when 4 mM EDTA was added just prior to silica, indicating that the elevation of intracellular calcium was dependent on extracellular sources of calcium.
Similar results were obtained using amorphous silica (Figure 2 ). Amorphorus silica is generally considered less fibrogenic than crystalline silica (23) . Consistent with decreased fibrogenic potential there was decreased ability to elevate intracellular calcium compared to crystalline silica when given at approximately equal surface areas, i.e., 40 and 80 pg/ml (to levels of approximately 200 and 300 nM over the same time period, respectively). In addition, elevation of intracellular calcium with amorphorous silica was also blocked using EDTA and therefore dependent on extracellular calcium.
The above experiments were conducted in the absence of added serum. However, in the absence of serum, silica does not stimulate human alveolar macrophages to release cytokines (data not shown). In the presence of serum, silica stimulates the release of a number of cytokines including IL-1 (16) . Therefore, the ability of silica to elevate intracellular calcium under conditions required for cytokine release were also examined. As shown in Figure 3 , neither 133 pg/ml crystalline nor 80 jig/ml amorphous silica caused noticable elevation of intracellular calcium in the presence of 10% FCS.
Silica-induced Activation of Intracellular Tyrosine Kinases
The above results suggest that under conditions required for cytokine release silica stimulation of human alveolar macrophages may proceed by a pathway independent of changes in intracellular calcium. Other studies indicated that silica also does not cause noticable changes in cAMP or cGMP levels (data not shown). However, recent studies from other laboratories show that tyrosine kinases are involved in endotoxin stimulation of neutrophils and mitogen stimulation of lymphocytes (24, 25) . Therefore, the potential involvement of tyrosine kinases in silica stimulation was examined by Western blot analysis using an antiphosphotyrosine antibody. Results of phosphotyrosine Western blots are shown for both 100 ng/ml LPS ( Figure   4A ) and 133 pg/ml crystalline silica ( Figure   4B ) stimulation for 24 hr then stimulated with 10 jig/ml LPS.
To determine if the priming effect of silica was associated with a potential tyrosine kinase pathway leading to cytokine release, MAP kinase activity was measured under similar conditions as described for Figure 5 . Macrophages were preincubated 30 60 CON for 24 hr with or without 33 pg/ml silica then stimulated with 100 ng/ml LPS. At various times after LPS stimulation, cells were solubilized, MAP kinase was immunoprecipitated and its activity quantitated. As shown in Figure 6 , LPS stimulated MAP kinase activity in a time-dependent manner that peaked slight, but significant, when cells were preincubated with 33 pg/ml silica for 24 hr then stimulated with 100 ng/ml LPS. The results were more pronounced, and almost reached significance (p= 0.05) when cells were preincubated with 133 jig/ml silica Discussion Both silica and chrysotile asbestos stimulate human alveolar macrophages. However, while both particulates stimulate cytokine release (16) , only asbestos stimulates superoxide anion production (13). These observations imply that either asbestos stimulates multiple pathways and one of them is similar to that stimulated by silica, or that the particulates stimulate independent pathways. We have already described that asbestos stimulates the phospholipase C/protein kinase C pathway (14) and opens a verapamil-sensitive calcium channel in alveolar macrophages (15 Time (min) Figure 6 . MAP kinase activity following endotoxin stimulation of control and silica-pretreated macrophages. Culture conditions were identical to the 33 pg/ml silicatreated cells described in Figure 5 . Different results were obtained when alveolar macrophages were incubated in the presence of 10% FCS prior to the addition of silica. In the presence of serum, neither form of silica was able to noticeably elevate intracellular calcium (Figure 3) . Although silica may elevate intracellular calcium at a later time point, there is a clear alteration in bioactivity when serum is present, consistent with previous obserations that the bioactivity of silica (macrophage superoxide anion production) can be modified significantly by addition of specific proteins such as immunoglobulins and albumin (13) . In addition, silica is more cytotoxic in the absence of serum, consistent with intracellular calcium changes in these two conditions. Furthermore, within this early time frame of approximately 10 min, silica was shown to stimulate intracellular kinases in the presence of serum as evidenced by the tyrosine phosphorylation results (Figure 4) . Therefore, silica can cause signal transduction without an elevation of intracellular calcium. Which model (with or without serum) of macrophage stimulation is more physiological is an important consideration. While neither one is ideal, the presence of certain serum components (proteins and lipids) that may mimic those present in the lung lining fluid layer may be better than only a balanced salt solution. Furthermore, we have observed that silica-stimulated cytokine release (e.g., IL-1v and TNF-ac) from human alveolar macrophages is much greater in the presence of serum.
Recent studies show that other cells such as lymphocytes can be stimulated by a tyrosine kinase-mediated pathway (24, 25) . Our results suggest that silica may stimulate human alveolar macrophages through such a pathway (Figure 4) . We observed increased tyrosine phosphorylation following either LPS or silica stimulation of a number of proteins, most notably at 46 and 80 kDa with LPS and 46 and 50 kDa with silica. Although these proteins remain to be identified, it may be speculated that the 46-kDa protein is a MAP kinase isoform.
Our results also show that a 24-hr preincubation with silica can prime human alveolar macrophages for enhanced release of IL-15 in response to LPS ( Figure 5 ). The effect was observed using low doses of silica and LPS and was pronounced with high doses of both silica and LPS. Consistent with the implication for the involvement of tyrosine phosphorylation in silica stimulation, MAP kinase activity was also enhanced following silica priming and correlated with the enhanced cytokine release. Therefore, silica can upregulate macrophages by some mechanism that results in increased MAP kinase activity and cytokine release to a second stimulus such as LPS. These results raise the possibility that bacterial infections could play some role in fibrogenesis.
In summary, silica increases intracellular calcium in a balanced salt solution medium. However, in the presence of 10% serum, which appears to be required for cytokine release, silica does not increase intracellular calcium levels. Silica by itself does stimulate tyrosine phosphorylation as well as prime macrophages for enhanced MAP kinase activity and cytokine release in response to a second stimulus such as LPS. Taken together, these results suggest that silica activates and modifies a tyrosine kinase pathway in human alveolar macrophages that may be important in the development of fibrosis.
